Function of RasGRP3 in the formation and progression of human breast cancer

Zs. Nagy

Research output: Contribution to journalMeeting abstract

Abstract

RasGRP3 is a member of the Ras guanine nucleotide releasing protein (RasGRP) family of the Ras-specific guanine nucleotide exchange factors. These proteins play important role in the regulation of the activity of Ras signaling pathway which constitutive activation is demonstrated in many cancer types. In the light of the this potential oncogenic effect, we investigated the putative alteration of expression and potential function of RasGRP3 in the formation and progression of human breast cancer. The RasGRP3 and phosphoRasGRP3 expressions were examined in human invasive ductal adenocarcinoma derived samples and cell lines (BT-474, JIMT-1, MCF7, SK-BR-3, MDA-MB-453, T-47D) both in mRNA (Q-PCR) and protein (Western blot; immunohistochemistry) levels. To explore the biological function of the protein, RasGRP3 knockdown cultures were established. To assess the role of RasGRP3 in the viability of cells, annexin-V/PI staining and MitoProbe TM DilC1 (5) assay were performed. To clarify the function of the protein in cell proliferation and in the development of chemotherapeutic resistance, CyQuant assay was performed. To observe the RasGRP3 function in tumor formation, the Severe combined immunodeficiency (SCID) mouse model was used. To investigate the role of the protein in Ras-related signaling Q-PCR and Western blot experiments were performed. RasGRP3 expression was elevated in human breast tumor tissue samples as well as in multiple human breast cancer cell lines. Down-regulation of RasGRP3 expression in breast cancer cells decreased cell proliferation, induced apoptosis in MCF7 cells, and sensitized T-47D cells to the action of drugs Tamoxifen and trastuzumab (Herceptin). Gene silencing of RasGRP3 reduced tumor formation in mouse xenografts as well. Inhibition of RasGRP3 expression also reduced Akt, ERK1/2 and estrogen receptor alpha phosphorylation downstream from IGF-I insulin like growth factor-I (IGF-I) or epidermal growth factor (EGF) stimulation confirming the functional role of RasGRP3 in the altered behavior of these cells. Taken together, our results suggest that RasGRP3 may have a role in the pathological behavior of breast cancer cells.
Original languageEnglish
Pages (from-to)75-75
Number of pages1
JournalActa Physiologica
Volume211
Issue numbers697
Publication statusPublished - Aug 2014
Externally publishedYes
EventJoint meeting of the Federation of European Physiological Societies (FEPS) and the Hungarian Physiological Society - Budapest, Hungary
Duration: 27 Aug 201430 Aug 2014

Fingerprint Dive into the research topics of 'Function of RasGRP3 in the formation and progression of human breast cancer'. Together they form a unique fingerprint.

  • Cite this